The mechanism of trastuzumab resistance on cancer has been reported in various ways, including the overexpression of insulin-like growth factor I (IGF-1) [64], overexpression of glycoprotein MUC4 [65], and constitutive P13K/Akt activity [66]. Here, IGF1 is linked to cancer.